Crown Lifters working capital

·UnclassifiedChart ›

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

116.64×	116.64×	97.83×	89.29×	104.96×	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
1,288.98×	1,288.98×	1,317.56×	832.71×	94.71×
−1,172.34×	−1,172.34×	−1,219.73×	−743.42×	10.25×
−1.84×	−1.71×	3.58×	−2.11×	1.69×
0.20×	0.20×	0.24×	0.38×	0.49×
1.07×	1.07×	2.51×	10.11×	2.78×
0.45×	0.45×	2.33×	3.68×	2.32×

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

CROWN₹103.00

Crown Lifters Limited

· Unclassified

₹ CrorePeersHINDCON PAR BALAXI GROBTEA TOTAL STEELCITY TEMBO VAISHALIMcap ₹119 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Receivable Days (DSO)	104.96	89.29	97.83	116.64	116.64
Payable Days (DPO)	94.71	832.71	1,317.56	1,288.98	1,288.98
Cash Conversion Cycle (days)	10.25	-743.42	-1,219.73	-1,172.34	-1,172.34
Working Capital Turnover	1.69	-2.11	3.58	-1.71	-1.84
Asset Turnover	0.49	0.38	0.24	0.20	0.20
Cash Conversion (CFO/Net Income)	2.78	10.11	2.51	1.07	1.07
CFO/EBITDA	2.32	3.68	2.33	0.45	0.45

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.